Health and Healthcare
Myriad's Alarming Alzheimer's Forecasts
Published:
Last Updated:
Myriad Genetics, Inc. (MYGN-NASDAQ) has issued a press release discussing a new study showing that the potential savings to the US healthcare system alone could be $4.0 Trillion from 2010 to 2050. It estimates that in 2030 the rate from today’s 5.1 million Americans with Alzheimer’s will grow to 7.7 million and then to 16 million by 2050.
What Myriad is doing is essentially promoting its Flurizan (currently in Phase II’s) and it is trying to speed things up by noting that the delay of even a year could have tremendous expense ramifications. We noted many of the other company names working in the sector after Barron’s ran a cover story on this epidemic that Barron’s left off.
These current numbers and projections are seeming to get worse and worse each year
Jon C. Ogg
May 15, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.
Robinhood set out to democratize investing to individuals, and it’s not slowing down. The app makes it possible to buy and sell stocks, mutual funds, trade options, and even cryptocurrencies like Bitcoin (BTC) and Ethereum (ETH).
With FDIC insurance ,an award winning design, and benefits like IRAs and more, Robinhood could be your path to a richer tomorrow.
Sign up today — click here to start your journey.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.